nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCB1—peripheral nervous system neoplasm	0.13	1	CbGaD
Verapamil—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.045	0.0713	CbGbCtD
Verapamil—ABCC10—Vincristine—peripheral nervous system neoplasm	0.036	0.057	CbGbCtD
Verapamil—ABCC10—Etoposide—peripheral nervous system neoplasm	0.033	0.0522	CbGbCtD
Verapamil—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0226	0.0359	CbGbCtD
Verapamil—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0226	0.0357	CbGbCtD
Verapamil—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.0225	0.0356	CbGbCtD
Verapamil—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0218	0.0345	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0215	0.034	CbGbCtD
Verapamil—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0211	0.0334	CbGbCtD
Verapamil—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0207	0.0329	CbGbCtD
Verapamil—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0196	0.031	CbGbCtD
Verapamil—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0163	0.0259	CbGbCtD
Verapamil—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0151	0.0239	CbGbCtD
Verapamil—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.015	0.0237	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.015	0.0237	CbGbCtD
Verapamil—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0142	0.0226	CbGbCtD
Verapamil—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0141	0.0224	CbGbCtD
Verapamil—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0139	0.022	CbGbCtD
Verapamil—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0127	0.0202	CbGbCtD
Verapamil—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0122	0.0194	CbGbCtD
Verapamil—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0112	0.0178	CbGbCtD
Verapamil—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0108	0.0171	CbGbCtD
Verapamil—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0103	0.0163	CbGbCtD
Verapamil—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00959	0.0152	CbGbCtD
Verapamil—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00942	0.0149	CbGbCtD
Verapamil—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0093	0.0147	CbGbCtD
Verapamil—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.00898	0.0142	CbGbCtD
Verapamil—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00868	0.0138	CbGbCtD
Verapamil—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00867	0.0137	CbGbCtD
Verapamil—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00852	0.0135	CbGbCtD
Verapamil—CACNA1S—pes—peripheral nervous system neoplasm	0.00798	0.201	CbGeAlD
Verapamil—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00785	0.0124	CbGbCtD
Verapamil—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00785	0.0124	CbGbCtD
Verapamil—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00752	0.0119	CbGbCtD
Verapamil—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.00718	0.0114	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00687	0.0109	CbGbCtD
Verapamil—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00687	0.0109	CbGbCtD
Verapamil—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00643	0.0102	CbGbCtD
Verapamil—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0061	0.00966	CbGbCtD
Verapamil—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00581	0.00921	CbGbCtD
Verapamil—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.00569	0.143	CbGeAlD
Verapamil—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00544	0.00862	CbGbCtD
Verapamil—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00515	0.00816	CbGbCtD
Verapamil—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00472	0.00748	CbGbCtD
Verapamil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00471	0.00746	CbGbCtD
Verapamil—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00454	0.00719	CbGbCtD
Verapamil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00437	0.00693	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00409	0.00648	CbGbCtD
Verapamil—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00351	0.00557	CbGbCtD
Verapamil—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00335	0.00531	CbGbCtD
Verapamil—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00322	0.0051	CbGbCtD
Verapamil—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00313	0.00495	CbGbCtD
Verapamil—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00307	0.00487	CbGbCtD
Verapamil—CACNA1D—cochlea—peripheral nervous system neoplasm	0.00288	0.0725	CbGeAlD
Verapamil—CACNA1D—internal ear—peripheral nervous system neoplasm	0.00273	0.0687	CbGeAlD
Verapamil—CACNB4—ganglion—peripheral nervous system neoplasm	0.00255	0.064	CbGeAlD
Verapamil—CACNA1A—nerve—peripheral nervous system neoplasm	0.00246	0.0619	CbGeAlD
Verapamil—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0021	0.00332	CbGbCtD
Verapamil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00201	0.00318	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00313	CbGbCtD
Verapamil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00184	0.00292	CbGbCtD
Verapamil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00199	CbGbCtD
Verapamil—CACNB4—trigeminal ganglion—peripheral nervous system neoplasm	0.00125	0.0314	CbGeAlD
Verapamil—CACNA1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00117	0.0293	CbGeAlD
Verapamil—CACNA1A—brainstem—peripheral nervous system neoplasm	0.00106	0.0266	CbGeAlD
Verapamil—CACNB3—trigeminal ganglion—peripheral nervous system neoplasm	0.000958	0.0241	CbGeAlD
Verapamil—SLC22A1—ganglion—peripheral nervous system neoplasm	0.000857	0.0215	CbGeAlD
Verapamil—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000797	0.02	CbGeAlD
Verapamil—CACNA1I—cerebellum—peripheral nervous system neoplasm	0.000663	0.0167	CbGeAlD
Verapamil—CACNB4—cerebellum—peripheral nervous system neoplasm	0.000546	0.0137	CbGeAlD
Verapamil—CACNA1A—cerebellum—peripheral nervous system neoplasm	0.000521	0.0131	CbGeAlD
Verapamil—CACNA1B—cerebellum—peripheral nervous system neoplasm	0.000508	0.0128	CbGeAlD
Verapamil—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	0.00047	0.0118	CbGeAlD
Verapamil—CACNA1G—cerebellum—peripheral nervous system neoplasm	0.000454	0.0114	CbGeAlD
Verapamil—ABCC10—parotid gland—peripheral nervous system neoplasm	0.000443	0.0111	CbGeAlD
Verapamil—CACNB1—cerebellum—peripheral nervous system neoplasm	0.000436	0.011	CbGeAlD
Verapamil—CACNB3—cerebellum—peripheral nervous system neoplasm	0.000418	0.0105	CbGeAlD
Verapamil—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000346	0.00871	CbGeAlD
Verapamil—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000314	0.00788	CbGeAlD
Verapamil—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000309	0.00778	CbGeAlD
Verapamil—CACNA1H—cerebellum—peripheral nervous system neoplasm	0.000297	0.00748	CbGeAlD
Verapamil—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000292	0.00735	CbGeAlD
Verapamil—CACNB2—cerebellum—peripheral nervous system neoplasm	0.000281	0.00706	CbGeAlD
Verapamil—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.000276	0.00693	CbGeAlD
Verapamil—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000275	0.00692	CbGeAlD
Verapamil—KCNJ11—cerebellum—peripheral nervous system neoplasm	0.000266	0.0067	CbGeAlD
Verapamil—ABCG2—parotid gland—peripheral nervous system neoplasm	0.00026	0.00653	CbGeAlD
Verapamil—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.000245	0.00617	CbGeAlD
Verapamil—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.000227	0.0057	CbGeAlD
Verapamil—ABCC10—cerebellum—peripheral nervous system neoplasm	0.000205	0.00516	CbGeAlD
Verapamil—SLC22A4—cerebellum—peripheral nervous system neoplasm	0.000193	0.00485	CbGeAlD
Verapamil—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.000177	0.00444	CbGeAlD
Verapamil—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000167	0.0042	CbGeAlD
Verapamil—ABCC1—cerebellum—peripheral nervous system neoplasm	0.000145	0.00365	CbGeAlD
Verapamil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00014	0.00117	CcSEcCtD
Verapamil—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00117	CcSEcCtD
Verapamil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00116	CcSEcCtD
Verapamil—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00014	0.00116	CcSEcCtD
Verapamil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00014	0.00116	CcSEcCtD
Verapamil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.00115	CcSEcCtD
Verapamil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000138	0.00115	CcSEcCtD
Verapamil—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000138	0.00115	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000138	0.00115	CcSEcCtD
Verapamil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000137	0.00114	CcSEcCtD
Verapamil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000137	0.00114	CcSEcCtD
Verapamil—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000137	0.00114	CcSEcCtD
Verapamil—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000136	0.00113	CcSEcCtD
Verapamil—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000136	0.00341	CbGeAlD
Verapamil—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.00113	CcSEcCtD
Verapamil—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000135	0.00113	CcSEcCtD
Verapamil—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000135	0.00339	CbGeAlD
Verapamil—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.00112	CcSEcCtD
Verapamil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.00112	CcSEcCtD
Verapamil—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00112	CcSEcCtD
Verapamil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00112	CcSEcCtD
Verapamil—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00112	CcSEcCtD
Verapamil—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00111	CcSEcCtD
Verapamil—Infection—Cisplatin—peripheral nervous system neoplasm	0.000133	0.00111	CcSEcCtD
Verapamil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000133	0.00111	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00111	CcSEcCtD
Verapamil—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Rash—Topotecan—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000132	0.0011	CcSEcCtD
Verapamil—Headache—Topotecan—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000131	0.00109	CcSEcCtD
Verapamil—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00013	0.00109	CcSEcCtD
Verapamil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Pain—Vincristine—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Constipation—Vincristine—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00013	0.00108	CcSEcCtD
Verapamil—Rash—Melphalan—peripheral nervous system neoplasm	0.000129	0.00108	CcSEcCtD
Verapamil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000129	0.00107	CcSEcCtD
Verapamil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000128	0.00107	CcSEcCtD
Verapamil—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00107	CcSEcCtD
Verapamil—SLC22A5—cerebellum—peripheral nervous system neoplasm	0.000128	0.00321	CbGeAlD
Verapamil—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000126	0.00105	CcSEcCtD
Verapamil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000125	0.00104	CcSEcCtD
Verapamil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000125	0.00104	CcSEcCtD
Verapamil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.00104	CcSEcCtD
Verapamil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000124	0.00104	CcSEcCtD
Verapamil—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000124	0.00103	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00103	CcSEcCtD
Verapamil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000123	0.00103	CcSEcCtD
Verapamil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000123	0.00103	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00103	CcSEcCtD
Verapamil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000123	0.00102	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000122	0.00102	CcSEcCtD
Verapamil—Infection—Etoposide—peripheral nervous system neoplasm	0.000122	0.00102	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.00101	CcSEcCtD
Verapamil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000122	0.00101	CcSEcCtD
Verapamil—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00101	CcSEcCtD
Verapamil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00012	0.001	CcSEcCtD
Verapamil—ABCG2—cerebellum—peripheral nervous system neoplasm	0.00012	0.00302	CbGeAlD
Verapamil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00012	0.000998	CcSEcCtD
Verapamil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000995	CcSEcCtD
Verapamil—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000119	0.000989	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000986	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000982	CcSEcCtD
Verapamil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000116	0.000967	CcSEcCtD
Verapamil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000965	CcSEcCtD
Verapamil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000115	0.000956	CcSEcCtD
Verapamil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000955	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000952	CcSEcCtD
Verapamil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00094	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000937	CcSEcCtD
Verapamil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000933	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000931	CcSEcCtD
Verapamil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000112	0.00093	CcSEcCtD
Verapamil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000927	CcSEcCtD
Verapamil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00011	0.00092	CcSEcCtD
Verapamil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00011	0.000918	CcSEcCtD
Verapamil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000109	0.000912	CcSEcCtD
Verapamil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000109	0.000909	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000909	CcSEcCtD
Verapamil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000109	0.000906	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000899	CcSEcCtD
Verapamil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000108	0.000898	CcSEcCtD
Verapamil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000896	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000891	CcSEcCtD
Verapamil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000891	CcSEcCtD
Verapamil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000106	0.000882	CcSEcCtD
Verapamil—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000876	CcSEcCtD
Verapamil—Pain—Etoposide—peripheral nervous system neoplasm	0.000105	0.000874	CcSEcCtD
Verapamil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000105	0.000874	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000867	CcSEcCtD
Verapamil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000866	CcSEcCtD
Verapamil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000104	0.000864	CcSEcCtD
Verapamil—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000862	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000862	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000843	CcSEcCtD
Verapamil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000101	0.000843	CcSEcCtD
Verapamil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000101	0.000839	CcSEcCtD
Verapamil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.0001	0.000835	CcSEcCtD
Verapamil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.000833	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000832	CcSEcCtD
Verapamil—Rash—Alitretinoin—peripheral nervous system neoplasm	9.91e-05	0.000826	CcSEcCtD
Verapamil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.9e-05	0.000825	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000824	CcSEcCtD
Verapamil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.87e-05	0.000822	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000821	CcSEcCtD
Verapamil—Headache—Alitretinoin—peripheral nervous system neoplasm	9.85e-05	0.000821	CcSEcCtD
Verapamil—Urticaria—Etoposide—peripheral nervous system neoplasm	9.75e-05	0.000812	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000811	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000809	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000807	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000803	CcSEcCtD
Verapamil—Vomiting—Vincristine—peripheral nervous system neoplasm	9.63e-05	0.000803	CcSEcCtD
Verapamil—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.61e-05	0.000801	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000801	CcSEcCtD
Verapamil—Sweating—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000797	CcSEcCtD
Verapamil—Rash—Vincristine—peripheral nervous system neoplasm	9.55e-05	0.000796	CcSEcCtD
Verapamil—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.54e-05	0.000795	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.54e-05	0.000795	CcSEcCtD
Verapamil—Headache—Vincristine—peripheral nervous system neoplasm	9.49e-05	0.000791	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.00078	CcSEcCtD
Verapamil—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.34e-05	0.000778	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—peripheral nervous system neoplasm	9.33e-05	0.000778	CcSEcCtD
Verapamil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.17e-05	0.000764	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000763	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.00076	CcSEcCtD
Verapamil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.04e-05	0.000753	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000752	CcSEcCtD
Verapamil—Nausea—Vincristine—peripheral nervous system neoplasm	9e-05	0.00075	CcSEcCtD
Verapamil—Flushing—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000749	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000748	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000747	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000743	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000741	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000735	CcSEcCtD
Verapamil—Asthenia—Etoposide—peripheral nervous system neoplasm	8.81e-05	0.000734	CcSEcCtD
Verapamil—Pruritus—Etoposide—peripheral nervous system neoplasm	8.68e-05	0.000723	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	8.63e-05	0.000719	CcSEcCtD
Verapamil—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000713	CcSEcCtD
Verapamil—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.52e-05	0.00071	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000706	CcSEcCtD
Verapamil—Rash—Cisplatin—peripheral nervous system neoplasm	8.45e-05	0.000704	CcSEcCtD
Verapamil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.44e-05	0.000703	CcSEcCtD
Verapamil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.4e-05	0.0007	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000696	CcSEcCtD
Verapamil—Flushing—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000693	CcSEcCtD
Verapamil—CYP2D6—cerebellum—peripheral nervous system neoplasm	8.23e-05	0.00207	CbGeAlD
Verapamil—Dizziness—Etoposide—peripheral nervous system neoplasm	8.12e-05	0.000676	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000675	CcSEcCtD
Verapamil—Nausea—Cisplatin—peripheral nervous system neoplasm	7.96e-05	0.000663	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000662	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.00066	CcSEcCtD
Verapamil—Vomiting—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.00065	CcSEcCtD
Verapamil—Agitation—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000645	CcSEcCtD
Verapamil—Rash—Etoposide—peripheral nervous system neoplasm	7.74e-05	0.000645	CcSEcCtD
Verapamil—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.73e-05	0.000644	CcSEcCtD
Verapamil—Headache—Etoposide—peripheral nervous system neoplasm	7.69e-05	0.000641	CcSEcCtD
Verapamil—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000631	CcSEcCtD
Verapamil—Syncope—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.00063	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000625	CcSEcCtD
Verapamil—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000621	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000617	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000612	CcSEcCtD
Verapamil—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000609	CcSEcCtD
Verapamil—Nausea—Etoposide—peripheral nervous system neoplasm	7.29e-05	0.000607	CcSEcCtD
Verapamil—Hypertension—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000606	CcSEcCtD
Verapamil—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000598	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000598	CcSEcCtD
Verapamil—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000598	CcSEcCtD
Verapamil—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000597	CcSEcCtD
Verapamil—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000591	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000585	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000584	CcSEcCtD
Verapamil—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000583	CcSEcCtD
Verapamil—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000578	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000574	CcSEcCtD
Verapamil—Oedema—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000573	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000573	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000571	CcSEcCtD
Verapamil—Infection—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000569	CcSEcCtD
Verapamil—Shock—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000564	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000563	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000561	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000559	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000554	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000553	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000553	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000553	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000547	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000541	CcSEcCtD
Verapamil—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000536	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000535	CcSEcCtD
Verapamil—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.00053	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.00053	CcSEcCtD
Verapamil—Infection—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000527	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000522	CcSEcCtD
Verapamil—Shock—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000522	CcSEcCtD
Verapamil—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000518	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000518	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000515	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000513	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000511	CcSEcCtD
Verapamil—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.00051	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000505	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000496	CcSEcCtD
Verapamil—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000494	CcSEcCtD
Verapamil—ABCB1—cerebellum—peripheral nervous system neoplasm	5.92e-05	0.00149	CbGeAlD
Verapamil—Constipation—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.00049	CcSEcCtD
Verapamil—Pain—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.00049	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000483	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.00048	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000476	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000473	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000472	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000472	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000467	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000457	CcSEcCtD
Verapamil—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000455	CcSEcCtD
Verapamil—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000454	CcSEcCtD
Verapamil—Pain—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000454	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000437	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000422	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000421	CcSEcCtD
Verapamil—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000411	CcSEcCtD
Verapamil—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000406	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000392	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000391	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000381	CcSEcCtD
Verapamil—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000379	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000375	CcSEcCtD
Verapamil—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000364	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000363	CcSEcCtD
Verapamil—Rash—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000361	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000361	CcSEcCtD
Verapamil—Headache—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000359	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000351	CcSEcCtD
Verapamil—Nausea—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.00034	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000337	CcSEcCtD
Verapamil—Rash—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000334	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000334	CcSEcCtD
Verapamil—Headache—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000332	CcSEcCtD
Verapamil—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000315	CcSEcCtD
Verapamil—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.01e-05	0.000255	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	2.01e-05	0.000255	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2e-05	0.000254	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	2e-05	0.000253	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.99e-05	0.000253	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.97e-05	0.00025	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.97e-05	0.00025	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ENO2—peripheral nervous system neoplasm	1.97e-05	0.00025	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.96e-05	0.000249	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—TH—peripheral nervous system neoplasm	1.94e-05	0.000247	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000246	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.93e-05	0.000245	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—TH—peripheral nervous system neoplasm	1.93e-05	0.000245	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—HRAS—peripheral nervous system neoplasm	1.93e-05	0.000245	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	1.93e-05	0.000244	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.92e-05	0.000244	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	1.91e-05	0.000243	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.91e-05	0.000243	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.9e-05	0.000241	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.87e-05	0.000237	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	1.85e-05	0.000235	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000235	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.83e-05	0.000232	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.82e-05	0.00023	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—BCHE—peripheral nervous system neoplasm	1.8e-05	0.000229	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.8e-05	0.000228	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—HRAS—peripheral nervous system neoplasm	1.79e-05	0.000227	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.79e-05	0.000227	CbGpPWpGaD
Verapamil—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.79e-05	0.000227	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.76e-05	0.000223	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.75e-05	0.000222	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.72e-05	0.000218	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—HRAS—peripheral nervous system neoplasm	1.7e-05	0.000215	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—TH—peripheral nervous system neoplasm	1.7e-05	0.000215	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.69e-05	0.000214	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.68e-05	0.000214	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.67e-05	0.000212	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.67e-05	0.000211	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—GNAS—peripheral nervous system neoplasm	1.66e-05	0.000211	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000211	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.66e-05	0.00021	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.65e-05	0.00021	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.65e-05	0.000209	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.63e-05	0.000207	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.63e-05	0.000207	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	1.62e-05	0.000205	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.61e-05	0.000204	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000203	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.6e-05	0.000203	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—GNAS—peripheral nervous system neoplasm	1.59e-05	0.000201	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.58e-05	0.000201	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.000201	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—GNAS—peripheral nervous system neoplasm	1.58e-05	0.0002	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000199	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.000198	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.56e-05	0.000198	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.56e-05	0.000198	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.55e-05	0.000197	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.55e-05	0.000197	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ABCB1—peripheral nervous system neoplasm	1.55e-05	0.000196	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.54e-05	0.000196	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.53e-05	0.000195	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.53e-05	0.000194	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.52e-05	0.000193	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.52e-05	0.000193	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	1.51e-05	0.000191	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.51e-05	0.000191	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.5e-05	0.00019	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.5e-05	0.00019	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.49e-05	0.000189	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—HRAS—peripheral nervous system neoplasm	1.49e-05	0.000189	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.48e-05	0.000188	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.47e-05	0.000187	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.47e-05	0.000187	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000185	CbGpPWpGaD
Verapamil—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.44e-05	0.000183	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.44e-05	0.000183	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	0.000181	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.41e-05	0.000179	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.39e-05	0.000176	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.000176	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000173	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ABCB1—peripheral nervous system neoplasm	1.36e-05	0.000172	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.000171	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.00017	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.32e-05	0.000168	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.32e-05	0.000167	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000167	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.31e-05	0.000166	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.3e-05	0.000165	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.3e-05	0.000164	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000164	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.28e-05	0.000162	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000162	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.27e-05	0.000161	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.27e-05	0.000161	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.26e-05	0.00016	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000159	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.25e-05	0.000159	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000158	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.24e-05	0.000157	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.24e-05	0.000157	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.23e-05	0.000156	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.000155	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.000154	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.21e-05	0.000154	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.21e-05	0.000153	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.21e-05	0.000153	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.000153	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.2e-05	0.000153	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.19e-05	0.000151	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.18e-05	0.000149	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.16e-05	0.000147	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.000146	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000144	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000143	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.13e-05	0.000143	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.11e-05	0.000141	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.11e-05	0.000141	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.11e-05	0.000141	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.1e-05	0.00014	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.1e-05	0.00014	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.09e-05	0.000138	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000137	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.08e-05	0.000137	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.08e-05	0.000137	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000136	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.06e-05	0.000135	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.06e-05	0.000135	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.000135	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000135	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.05e-05	0.000134	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.000134	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.000133	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	0.000132	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.00013	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.02e-05	0.00013	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.01e-05	0.000129	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1e-05	0.000127	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.87e-06	0.000125	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.81e-06	0.000124	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	9.72e-06	0.000123	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.68e-06	0.000123	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	9.67e-06	0.000123	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	9.66e-06	0.000123	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	9.58e-06	0.000122	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.54e-06	0.000121	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.5e-06	0.000121	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	9.45e-06	0.00012	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.4e-06	0.000119	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	9.4e-06	0.000119	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	9.24e-06	0.000117	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	9.2e-06	0.000117	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.06e-06	0.000115	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	9.01e-06	0.000114	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	8.79e-06	0.000112	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	8.67e-06	0.00011	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	8.55e-06	0.000109	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	8.48e-06	0.000108	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.39e-06	0.000107	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	8.32e-06	0.000106	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8.18e-06	0.000104	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	8.17e-06	0.000104	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	8.07e-06	0.000102	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.98e-06	0.000101	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.95e-06	0.000101	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	7.89e-06	0.0001	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AKT1—peripheral nervous system neoplasm	7.82e-06	9.93e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.79e-06	9.89e-05	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	7.76e-06	9.86e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.74e-06	9.83e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	7.68e-06	9.75e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.62e-06	9.67e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.51e-06	9.53e-05	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AKT1—peripheral nervous system neoplasm	7.35e-06	9.33e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.31e-06	9.27e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.25e-06	9.2e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.13e-06	9.05e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.95e-06	8.83e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6.92e-06	8.78e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	6.72e-06	8.53e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.71e-06	8.52e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.69e-06	8.49e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.66e-06	8.46e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.6e-06	8.38e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.5e-06	8.25e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	6.37e-06	8.09e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	6.27e-06	7.96e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.17e-06	7.84e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.15e-06	7.81e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	6.13e-06	7.78e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.02e-06	7.65e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.01e-06	7.63e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.89e-06	7.48e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.8e-06	7.37e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.75e-06	7.3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	5.69e-06	7.23e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.68e-06	7.21e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.66e-06	7.19e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.63e-06	7.15e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.42e-06	6.88e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.37e-06	6.82e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.34e-06	6.78e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.31e-06	6.74e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.29e-06	6.72e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.21e-06	6.61e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	4.85e-06	6.16e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.81e-06	6.11e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.74e-06	6.01e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.65e-06	5.9e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.62e-06	5.87e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.59e-06	5.82e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.52e-06	5.74e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—peripheral nervous system neoplasm	4.52e-06	5.73e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—peripheral nervous system neoplasm	4.49e-06	5.7e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.39e-06	5.58e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.36e-06	5.53e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.32e-06	5.48e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—peripheral nervous system neoplasm	4.28e-06	5.44e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.28e-06	5.43e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—peripheral nervous system neoplasm	4.25e-06	5.4e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.24e-06	5.38e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—peripheral nervous system neoplasm	3.74e-06	4.74e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.71e-06	4.71e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.69e-06	4.69e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.62e-06	4.6e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	3.55e-06	4.5e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.54e-06	4.5e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	3.49e-06	4.43e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.49e-06	4.43e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	3.44e-06	4.37e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	3.35e-06	4.25e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.13e-06	3.98e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.92e-06	3.7e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.85e-06	3.62e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.8e-06	3.55e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.62e-06	3.33e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.49e-06	3.17e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.31e-06	2.93e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.29e-06	2.9e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.13e-06	2.7e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.69e-06	2.15e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.65e-06	2.1e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.28e-06	1.62e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.25e-06	1.58e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.18e-06	1.49e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-06	1.48e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.96e-07	1.26e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.69e-07	9.76e-06	CbGpPWpGaD
